149 results
8-K
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
for all performance objectives) (the “Unvested CVR Consideration”), less any required deductions and withholdings for income tax and National Insurance
8-K
EX-2.2
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
of the Transaction Agreement) and Rights Agent may require payment of a sum sufficient to cover any stamp duty or other transfer Tax or charge that is imposed … , Purchaser or any of its Subsidiaries is required under Applicable Law to deduct or withhold any employee Tax (including any employee National Insurance
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
or tax advice.
Orchard shareholders may not use any electronic address or fax number provided in this Notice or in any related documents … deliverables, when used in relation to holders of Orchard ADSs.
“VAT” means (i) any tax charged or imposed pursuant to Council Directive 2006/112/EC
8-K
ORTX
Orchard Therapeutics plc
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
Court of Justice of England and Wales, satisfaction of other closing conditions to consummate the acquisition, anticipated tax treatment, unforeseen … and market developments and conditions; (xi) the evolving legal, regulatory and tax regimes under which Orchard operates; (xii) potential business uncertainty
8-K
EX-99.1
ixf9n1sdv32wa
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
PREM14A
2bojrv6ssez3 9s5eb
3 Nov 23
Preliminary proxy related to merger
5:11pm
DEFA14A
pghcpiz9b77
17 Oct 23
Additional proxy soliciting materials
4:32pm
DEFA14C
aagar 97n80gai1n9f9
5 Oct 23
Additional information
5:26pm
DEFA14C
to5l l3dbxx0why20ydt
5 Oct 23
Additional information
4:48pm
DEFA14C
8owsn003zbw
5 Oct 23
Additional information
4:45pm
DEFA14C
sylql2
5 Oct 23
Additional information
4:43pm
DEFA14C
m3kg33 jlbvjr
5 Oct 23
Additional information
4:40pm
DEFA14A
bxn8f
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
449p6tl5gus4
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-2.1
yhkw6mcb9ts3ur xc3
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-10.1
lia63maojtmoaqvmm4yp
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-99.1
tf419wufd9 5715
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
424B3
8dtk2
21 Aug 23
Prospectus supplement
4:32pm
S-8
EX-5.1
dl1or nhdht57qy0k9oh
10 Aug 23
Registration of securities for employees
5:04pm